There is an Erratum (September 2003) associated with this News and Views.
A new piece of the ALS puzzle
John L Cleveland
John L. Cleveland is in the Department of Biochemistry at St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. john.cleveland@stjude.org
The molecular pathogenesis of most forms of amyotrophic lateral sclerosis (ALS) is poorly understood. Now, reduced expression of vascular endothelial growth factor (VEGF) is shown to be a risk factor for contracting ALS. Addition of Vegf in mice is shown to protect motoneurons from damage.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
